Trial Profile
comparison of the effect of Fingolimode and Betaferon (high dose) in decreasing the symptoms and relapse rates of MS patients whose treatment with Betaferon (low dose) was failed. - E.D.S.S
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Sep 2016
Price :
$35
*
At a glance
- Drugs Fingolimod (Primary) ; Interferon beta-1b
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 22 Sep 2016 New trial record